Early Neurological Deterioration after Recanalization Treatment in Patients with Acute Ischemic Stro

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:fxl207111
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Early neurological deterioration (END) is a prominent issue after recanalization treatment.However,few studies have reported the characteristics of END after endovascular treatment (EVT) as so far.This study investigated the incidence,composition,and outcomes of END after intravenous recombinant tissue plasminogen activator (Ⅳ rt-PA) and EVT of acute ischemic stroke,and identified risk factors for END.Methods:Medical records of patients who received recanalization treatment between January 1,2014,and December 31,2015 were reviewed.Patients were classified into Ⅳ rt-PA or EVT group according to the methods of recanalization treatment.The END was defined as an increase in the National Institutes of Health Stroke Scale (NIHSS) ≥4 or an increase in Ia of NIHSS ≥1 within 72 h after recanalization treatment.Clinical data were compared between the END and non-END subgroups within each recanalization group.Results:Of the 278 patients included in the study,the incidence of END was 34.2%.The incidence rates of END were 29.8% in the Ⅳ rt-PA group and 40.2% in the EVT group.Ischemia progression (68.4%) was the main contributor to END followed by vasogenic cerebral edema (21.1%) and symptomatic intracranial hemorrhage (10.5%).Multivariate logistic regression showed that admission systolic blood pressure (SBP) ≥160 mmHg (odds ratio [OR]:2.312,95% confidence interval [CI]:1.105-4.837) and large artery occlusion after Ⅳ rt-PA (OR:3.628,95% CI:1.482-8.881) independently predicted END after Ⅳ rt-PA;and admission SBP ≥140 mmHg (OR:5.183,95% CI:1.967-13.661),partial recanalization (OR:4.791,95% CI:1.749-13.121),and nonrecanalization (OR:5.952,95% CI:1.841-19.243)independently predicted END after EVT.The mortality rate and grave outcome rate at discharge of all the END patients (26.3% and 55.8%) were higher than those of all the non-END patients (1.1% and 18.6%;P < 0.01).Conclusions:END was not an uncommon event and associated with death and grave outcome at discharge.High admission SBP and unsatisfactory recanalization of occluded arteries might predict END.
其他文献
为了了解泽泻辛烯基琥珀酸淀粉酯的应用性能,促进泽泻淀粉的开发.本实验对泽泻不同取代度的辛烯基琥珀酸淀粉酯糊的性质进行研究,结果表明:(1)随着取代度的增加.淀粉酯糊的透
本文主要研究NFC橙汁中叶酸的研究方法及检测方法,并概述了叶酸在食品工业、医药、饲料方面的应用.最后,论述了NFC橙汁中叶酸的发展前景.
目的 探讨丹红注射液治疗慢性肺源性心脏病的疗效.方法 慢性肺源性心脏病70例随机分为丹红注射液组35例和对照组35例,两组均行常规治疗,治疗组加用丹红注射液20 ml配入5%葡萄
本文讨论了花生中水溶性膳食纤维的提取方法及其特性.在水浴温度T=100℃,pH=7,时间t=5mia.提取液用量为10mL/g时,其提取率可达6.98%.并研究了它在冰淇淋和果粒橙汁中的应用.
以新鲜百合和大米为原料,采用非酶解工艺制备出一种营养全面、风味独特的饮料.以感官评分和离心沉淀率为指标,探讨了加水量以及卡拉胶、蔗糖脂肪酸酯和蔗糖的添加量对饮料质
Background:White matter lesions (WMLs) are common findings in brain magnetic resonance imaging (MRI) and are strongly associated with stroke incidence,recurrenc
目的观察稳心颗粒联合美托洛尔治疗早搏的临床疗效。方法选择167例早搏患者随机分为治疗组(稳心颗粒联合美托洛尔组)89例,对照组(美托洛尔组)78例,治疗四周,评价其治疗早搏的
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥
期刊
尿激酶溶栓是目前治疗急性脑梗死,降低致残率,恢复肢体功能的关键治疗措施之一,但超早期大剂量溶栓容易并发出血等危险,小剂量则不能达到溶栓疗效。近年来我们采用小剂量尿激